Effect of Dapagliflozin on Renal Oxygen Delivery and Consumption in T2DM and NGT Subjects

被引：0
|
作者：
Tripathy, Devjit
Chen, Xi
Chilton, Robert
Hansis-Diarte, Andrea A.
Salehi, Marzieh
Solis-Herrera, Carolina
Cersosimo, Eugenio
Defronzo, Ralph A.
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-869-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
869-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Sitagliptin in Hispanic Subjects with T2DM
    Raji, Annaswamy
    Long, Jianmin
    O'Neill, Edward A.
    Engel, Samuel S.
    DIABETES, 2017, 66 : A322 - A322
  • [22] Perioperative Liraglutide Therapy for Japanese Subjects With T2DM
    Katagiri, Naoko
    Kaneko, Shizuka
    Tahara, Yumiko
    Sato, Yuichi
    Hamano, Kumiko
    DIABETES, 2013, 62 : A268 - A268
  • [23] Effect of type 2 diabetes (T2DM) on muscle protein metabolism in older subjects
    Fujita, S
    Rasmussen, BB
    Cadenas, JG
    Bell, JA
    Volpi, E
    FASEB JOURNAL, 2006, 20 (04): : A556 - A556
  • [24] Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes (T2DM)
    Grotz, VL
    Henry, RR
    McGill, JB
    Prince, MJ
    Shamoon, H
    Trout, JR
    Pi-Sunyer, FX
    DIABETES, 2002, 51 : A400 - A400
  • [25] Restitution of Glucose Disposition With Lixisenatide in T2DM Subjects
    Becker, Reinhard H.
    Kapitza, Christoph
    Stechl, Jens
    Ruus, Peter
    Msihid, Jerome
    DIABETES, 2012, 61 : A279 - A279
  • [26] White rice consumption increases risk of T2DM
    Nature Reviews Endocrinology, 2012, 8 (6) : 322 - 322
  • [27] Cardio-renal effect of dapagliflozin and dapagliflozin- saxagliptin combination on CD34+ve hematopoietic stem cells (HSCs) and podocyte specific markers in type 2 diabetes (T2DM) subjects: a randomized trial
    Nandula, Seshagiri Rao
    Jain, Arad
    Sen, Sabyasachi
    STEM CELL RESEARCH & THERAPY, 2025, 16 (01)
  • [28] The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
    Berezin, Alexander A.
    Fushtey, Ivan M.
    Berezin, Alexander E.
    BIOMEDICINES, 2022, 10 (07)
  • [29] Durability of Dapagliflozin Treatment Response in Patients With T2DM: 2-Year Results
    Salsali, Afshin
    Rohwedder, Katja
    Mansfield, Traci
    Martin, Paula
    Wei, Li
    Parikh, Shamik
    DIABETES, 2012, 61 : A264 - A264
  • [30] Dapagliflozin, Metformin-XR, or Both Together as Initial Therapy for T2DM
    Henry, Robert R.
    Murray, Alexander V.
    Marmolejo, Marisol Herrera
    Hennicken, Delphine
    Ptaszynska, Agata
    List, James F.
    DIABETES, 2011, 60 : A84 - A84
12345